2008 Attendees

This is the list of companies and organisations who will be attending the European Life Science CEO Forum for Investing & Partnering in Biotech - Medtech - Speciality Pharma & Emerging Markets, Zurich 08.

3i Deutschland GmbH
3i Group
4-Antibody AG
Abingworth Management Limited
Ablynx nv
ABN AMRO Rothschild
ACE BioSciences A/S
Actelion
Adamant Biomedical Investments
Advent Venture Partners
Adveq Management
Advisor
Affitech AS
AGF Private Equity
Alpha Associates AG
Alpharma Inc
Alta Berkeley
AM-Pharma
Aravis Venture Associates AG
Atila Ventures GmbH
Atlas Venture
Azemos Partner AG
Baigo Capital GmbH
Bank Sal. Oppenheim jr. & Cie. (Switzerland) Ltd.
Bank Vontobel
BankInvest Biomedical Venture
BB Biotech Ventures
Berlin Partner GmbH
Bio IB, LLC
Biolitec AG
BioMedInvest AG
Bionest
BioNet Holding GmbH
BioScience Managers Limited
Bloomberg News
Breslin AG
CDC Innovation
Cepa Biotech GmbH
Citigate Dewe Rogerson
CMS-ConsulMed Services
College Hill
Consultant
Covagen AG
Creathor Venture Management GmbH
Credit Suisse
Cyclacel Pharmaceuticals, Inc.
DBV Technologies
Deloitte AG
Direvo Biotech AG
Dr Hartmann + Partner
DZ Bank
Edmond de Rothschild Investment Partners
EFG Private Bank AG
Endeavour Vision SA
Equicore Beteiligungs
Equity Development Ltd.
ErgoNex Pharma GmbH
Esperante Ventures BV
EUSA Pharma
Exane BNP Paribas
F. Hoffmann-La Roche
Ferghana Partners
Forbion Capital Partners
GiMV NV
GlaxoSmithKline
Global Life Science Ventures
Grace Advisory
Greater Zurich Area
Greystone Ventures Group Inc.
Handelszeitung
HBM Partners AG
HealthCap
Helvea SA
High Tech Private Equity
Hutchison MediPharma Limited
IE Life Science Engineering
ImVisioN GmbH
InnovationsKapital
Intelligence Dynamics
InterPharmaLink AG
Invest in Denmark
INVEST SECURITIES
Jado Technologies
Kenta Biotech AG
Kiadis Pharma
Kresta, Schnider & Partners
Landsbanki Kepler
Le Temps
Lectus Therapeutics Ltd.
Lehman Brothers Europe
LEK Consulting
Life Science & Financing - BRESLIN
Lipoxen plc.
LSP
Matignon Technologies
Merck Serono Internationa S.A.
Metalife AG
Michael Page International (Switzerland) AG
Molecular Partners AG
MolMed S.p.A
MorphoSys AG
Mutabilis SA
MVM Life Science Partners
NASA – Johnson Space Center
NBGI Ventures
NeoMed
Nerites Corporation
Nextech Venture
NGN Capital
Nitec Pharma AG
NOLabs AB
NovaQuest
Novartis International AG
Novo A/S
novosom AG (DE)
NYSE Euronext
NZB Neue Zurcher Bank
Onyvax Ltd
Orion Healthcare Equity Partners
Oxford Genome Sciences Ltd.
Palau Pharma, S.A.
Pantec Biosolutions AG
Paul Capital Partners
PEPPERMINT. Financial Partners
Pernet Portfolio Management
Pfizer, Inc.
Pharmabank Pty Ltd
PharmaVentures Ltd.
Pharmawave Ltd
Pharmicell Europe GmbH
Photo Dynamic Therapy LLC
Praxim SA
Probiodrug AG
ProtAffin Biotechnologie AG
Proteome Factory AG
Quisisana Holding AG
Redbiotec AG
S.M.R. Interimsmanagement and Consulting GmbH
Sal. Oppenheim Jr. & Cie
SAM Group
Santaris Pharma  A/S
Scottish Widows Investment Partnership
SDP Technology Limited
SEED
Sofinnova Partners
Stierli Investor Relations
Stratos Bio
Suterscience LLC
Swiss Biotech
SWX Swiss Exchange AG
Symetis SA
T2Cure GmbH
Technology Consulting
The Rainbow Seed Fund
Trigon Medical AG
Tudor Reilly
TVM Capital
Uniobioscreen SA
Urodynamix Technologies Ltd
Ventech
Ventis Inc.
Venture Valuation AG
Vesalius Biocapital
VI Partners AG
Viscardi AG
Vita 34 International AG
Vivendy Therapeutics Ltd
Warburg Pincus LLC
Wellington Partners
Wilex AG